The Self-inflating Resuscitation Device industry trends over the past 18 months have pivoted toward single-use, eco-polymer designs that cut cross-contamination risk without sacrificing stroke volume accuracy. In June 2023, MediSync acquired Swedish start-up AirGuard AB for $42 million, gaining a patented antimicrobial bladder film already validated under Europeโs new MDR 2017/745 classification. Partnership activity accelerated when VitalVent and Teladoc jointly launched a connected BVM in Q1 2024 that streams tidal-volume data to EMS dashboards, opening a reimbursement pathway under the U.S. CMS ET3 program. Regulatory momentum followed: Health Canada now exempts emergency-use self-inflating bags from traditional MDL timelines if manufacturers file a real-world evidence plan, prompting Zoll to fast-track its NeoFlex+ device for neonatal transport. Enterprise buyers are shifting procurement from price-based tenders to total-cost-of-ownership models that include device recycling credits, a move that helped Laerdal secure a five-year, $90 million framework with NHS England last October. Finally, Series A funding surpassed $120 million sector-wide in 2023, with Ventura Healthโs $18 million round earmarked for Southeast Asian assembly hubs to serve price-sensitive ASEAN markets.